REBECCA JEPPSON: Open Payments
NPI 1033351895 · REXBURG, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 32 payments from 7 companies in 2025. Trend: 2023 $331 · 2024 $741 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $187 |
| Axsome Therapeutics, Inc. | 5 | $128 |
| Lilly USA, LLC | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $12 |
Products named: Auvelity, QULIPTA, MOUNJARO, VRAYLAR, AJOVY, LILETTA, XIFAXAN, SYNCHROMEDII.
Industry payments across ID — which companies pay providers there.
